Cumulative incidence of leukemia relapse after T cell–depleted haploidentical transplantation with regulatory and conventional T-cell immunotherapy in the presence or absence of donor-versus-recipient NK-cell alloreactivity. Transplantation from NK alloreactive donors reduced AML relapse but not ALL relapse (as previously demonstrated in the standard T cell–depleted haploidentical protocol).^18-22,93,94